These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 37375783)

  • 21. Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium: GLP-1R mediated effects in human myocardium.
    Wallner M; Kolesnik E; Ablasser K; Khafaga M; Wakula P; Ljubojevic S; Thon-Gutschi EM; Sourij H; Kapl M; Edmunds NJ; Kuzmiski JB; Griffith DA; Knez I; Pieske B; von Lewinski D
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):365-75. PubMed ID: 26432951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liraglutide Attenuates Myocardial Ischemia/Reperfusion Injury Through the Inhibition of Necroptosis by Activating GLP-1R/PI3K/Akt Pathway.
    Zhou G; Wu H; Yang J; Ye M; Liu D; Li Y; Zhang D; Zhang J; Yang Q; Liu Y
    Cardiovasc Toxicol; 2023 Apr; 23(3-4):161-175. PubMed ID: 36934206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Glucose Attenuates Cardioprotective Effects of Glucagon-Like Peptide-1 Through Induction of Mitochondria Dysfunction
    Pan X; Li C; Gao H
    Front Physiol; 2021; 12():648399. PubMed ID: 34054568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harnessing the therapeutic potential of glucagon-like peptide-1: a critical review.
    Baggio LL; Drucker DJ
    Treat Endocrinol; 2002; 1(2):117-25. PubMed ID: 15765627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.
    Holz GG
    Horm Metab Res; 2004; 36(11-12):787-94. PubMed ID: 15655710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications.
    Manandhar B; Ahn JM
    J Med Chem; 2015 Feb; 58(3):1020-37. PubMed ID: 25349901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Essential Role Of High Glucose-Induced Overexpression Of PKCβ And PKCδ In GLP-1 Resistance In Rodent Cardiomyocytes.
    Pan X; Chen J; Wang T; Zhang M; Wang H; Gao H
    Diabetes Metab Syndr Obes; 2019; 12():2289-2302. PubMed ID: 31807042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose.
    Zhang Y; Han C; Zhu W; Yang G; Peng X; Mehta S; Zhang J; Chen L; Liu Y
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection.
    Ussher JR; Baggio LL; Campbell JE; Mulvihill EE; Kim M; Kabir MG; Cao X; Baranek BM; Stoffers DA; Seeley RJ; Drucker DJ
    Mol Metab; 2014 Aug; 3(5):507-17. PubMed ID: 25061556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular actions of incretin-based therapies.
    Ussher JR; Drucker DJ
    Circ Res; 2014 May; 114(11):1788-803. PubMed ID: 24855202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic exposure to GLP-1R agonists promotes homologous GLP-1 receptor desensitization in vitro but does not attenuate GLP-1R-dependent glucose homeostasis in vivo.
    Baggio LL; Kim JG; Drucker DJ
    Diabetes; 2004 Dec; 53 Suppl 3():S205-14. PubMed ID: 15561912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GLP-1 and GIP receptor signaling in beta cells - A review of receptor interactions and co-stimulation.
    Mayendraraj A; Rosenkilde MM; Gasbjerg LS
    Peptides; 2022 May; 151():170749. PubMed ID: 35065096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-α.
    Siraj MA; Mundil D; Beca S; Momen A; Shikatani EA; Afroze T; Sun X; Liu Y; Ghaffari S; Lee W; Wheeler MB; Keller G; Backx P; Husain M
    J Clin Invest; 2020 Mar; 130(3):1392-1404. PubMed ID: 31985487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic hyperglycemia downregulates GLP-1 receptor signaling in pancreatic β-cells via protein kinase A.
    Rajan S; Dickson LM; Mathew E; Orr CM; Ellenbroek JH; Philipson LH; Wicksteed B
    Mol Metab; 2015 Apr; 4(4):265-76. PubMed ID: 25830090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of insulin analogs and glucagon-like peptide-1 receptor agonists on proliferation and cellular energy metabolism in papillary thyroid cancer.
    He L; Zhang S; Zhang X; Liu R; Guan H; Zhang H
    Onco Targets Ther; 2017; 10():5621-5631. PubMed ID: 29200876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
    Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M
    Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The intestine responds to heart failure by enhanced mitochondrial fusion through glucagon-like peptide-1 signalling.
    Naruse G; Kanamori H; Yoshida A; Minatoguchi S; Kawaguchi T; Iwasa M; Yamada Y; Mikami A; Kawasaki M; Nishigaki K; Minatoguchi S
    Cardiovasc Res; 2019 Nov; 115(13):1873-1885. PubMed ID: 30629149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts.
    Zhao T; Parikh P; Bhashyam S; Bolukoglu H; Poornima I; Shen YT; Shannon RP
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1106-13. PubMed ID: 16489128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing incretin action for the treatment of type 2 diabetes.
    Drucker DJ
    Diabetes Care; 2003 Oct; 26(10):2929-40. PubMed ID: 14514604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
    Scrocchi LA; Marshall BA; Cook SM; Brubaker PL; Drucker DJ
    Diabetes; 1998 Apr; 47(4):632-9. PubMed ID: 9568697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.